当前位置:首页 - 行情中心 - 翔宇医疗(688626) - 财务分析 - 现金流量表

翔宇医疗

(688626)

  

流通市值:67.12亿  总市值:67.12亿
流通股本:1.60亿   总股本:1.60亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金445,958,526.46195,165,280.42941,559,024.65645,583,603.09
  收到的税费返还12,821,456.833,500,993.1517,674,654.4812,966,123.45
  收到其他与经营活动有关的现金17,140,401.178,506,060.5466,629,874.9134,831,988.89
  经营活动现金流入小计475,920,384.46207,172,334.111,025,863,554.04693,381,715.43
  购买商品、接受劳务支付的现金177,567,478.3961,411,784.56272,586,969.7213,499,494.6
  支付给职工以及为职工支付的现金152,852,421.1769,991,849.39305,448,020.96241,620,921.61
  支付的各项税费29,861,709.2316,022,223.8764,824,266.651,986,550.71
  支付其他与经营活动有关的现金71,698,088.4935,883,750.59193,187,517.22115,077,243.93
  经营活动现金流出小计431,979,697.28183,309,608.41836,046,774.48622,184,210.85
  经营活动产生的现金流量净额43,940,687.1823,862,725.7189,816,779.5671,197,504.58
二、投资活动产生的现金流量:
  收回投资收到的现金7,000,000--5,150,712
  取得投资收益收到的现金-299,285.06923,882.89984,195.39
  处置固定资产、无形资产和其他长期资产收回的现金净额10,000-79,638.2726,252.93
  处置子公司及其他营业单位收到的现金净额--5,150,712-
  收到的其他与投资活动有关的现金475,786,610.465,000,000180,000,000100,000,000
  投资活动现金流入小计482,796,610.465,299,285.06186,154,233.16106,161,160.32
  购建固定资产、无形资产和其他长期资产支付的现金116,681,314.4437,060,678.27287,183,038.88251,271,437.94
  投资支付的现金20,000,00010,000,0005,750,000-
  支付其他与投资活动有关的现金299,278,960.4825,000,000289,509,726.01150,000,000
  投资活动现金流出小计435,960,274.9272,060,678.27582,442,764.89401,271,437.94
  投资活动产生的现金流量净额46,836,335.54-66,761,393.21-396,288,531.73-295,110,277.62
三、筹资活动产生的现金流量:
  吸收投资收到的现金---66,807,160
  取得借款收到的现金164,852,156.62164,852,156.62300,626,243.38263,693,438.9
  收到其他与筹资活动有关的现金365,400,000294,900,000507,587,160488,000,000
  筹资活动现金流入小计530,252,156.62459,752,156.62808,213,403.38818,500,598.9
  偿还债务支付的现金130,668,714.1710,000,000529,707,400298,990,000
  分配股利、利润或偿付利息支付的现金30,796,710.52,208,760.7344,434,165.542,475,118.72
  支付其他与筹资活动有关的现金398,086,625.72348,500,00047,007,519.35221,896,833.49
  筹资活动现金流出小计559,552,050.39360,708,760.73621,149,084.85563,361,952.21
  筹资活动产生的现金流量净额-29,299,893.7799,043,395.89187,064,318.53255,138,646.69
四、汇率变动对现金及现金等价物的影响273,518.51178,012.27-249,523.56-6,128.23
五、现金及现金等价物净增加额61,750,647.4656,322,740.65-19,656,957.231,219,745.42
  加:期初现金及现金等价物余额683,255,595.23683,255,595.23702,912,552.43702,912,552.43
  期末现金及现金等价物余额745,006,242.69739,578,335.88683,255,595.23734,132,297.85
补充资料:
  净利润39,894,339.69-75,986,946.04-
  资产减值准备4,325,780.07-8,064,545.2-
  固定资产和投资性房地产折旧22,584,452.8-43,966,500.38-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧22,584,452.8-43,966,500.38-
  无形资产摊销5,883,108.68-8,627,545.1-
  长期待摊费用摊销2,981,048.3-8,170,632.91-
  处置固定资产、无形资产和其他长期资产的损失-8,964.16--26,252.93-
  固定资产报废损失--178,374.86-
  公允价值变动损失-590,542.25--501,026-
  财务费用2,977,629.01-5,886,655.58-
  投资损失-6,279,726.16--5,939,079.55-
  递延所得税-4,576,429.33--4,366,403.22-
  其中:递延所得税资产减少-4,576,429.33--4,366,403.22-
  存货的减少-54,724,897.62--74,267,559.48-
  经营性应收项目的减少-3,161,172.24-5,130,536.48-
  经营性应付项目的增加28,656,797.45-95,810,648.89-
  其他--16,581,049.95-
  现金的期末余额745,006,242.69-683,255,595.23-
  减:现金的期初余额683,255,595.23-702,912,552.43-
  现金及现金等价物的净增加额61,750,647.46--19,656,957.2-
公告日期2026-08-292026-04-242026-04-242025-10-31
审计意见(境内)标准无保留意见
TOP↑